The experimental production of ischemic facial paralysis.
D000804:Angiotensin II / Q000009:adverse effects; D000818:Animals; D004285:Dogs; D004487:Edema / Q000209:etiology; D004837:Epinephrine / Q000009:adverse effects; D005154:Facial Nerve / Q000098:blood supply* / Q000187:drug effects; D005158:Facial Paralysis / Q000209:etiology*; D066298:In Vitro Techniques; D007511:Ischemia / Q000150:complications*; D009410:Nerve Degeneration; D010656:Phenylephrine / Q000009:adverse effects; D011817:Rabbits; D051381:Rats; D012965:Sodium Chloride / Q000009:adverse effects; D014650:Vasa Nervorum
D000804:Angiotensin II; D010656:Phenylephrine; D012965:Sodium Chloride; D004837:Epinephrine